Liposomal Daunorubicin in Treating Patients With HIV-Related Kaposi's Sarcoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00427414
Recruitment Status : Terminated (Terminated due to slow accrual.)
First Posted : January 29, 2007
Last Update Posted : April 29, 2015
National Cancer Institute (NCI)
The EMMES Corporation
Information provided by (Responsible Party):
AIDS Malignancy Consortium

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Primary Completion Date : November 2010
  Study Completion Date : November 2011